ArticleSurgical endoscopy2025
Optimal lymph node dissection thresholds for early-stage esophageal squamous cell carcinoma: a retrospective multicenter study.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEsophageal cancer (EC), especially esophageal squamous cell carcinoma (ESCC) in China, is a major cause of cancer-related mortality. While lymph node (LN) dissection is crucial for staging and prognosis in early-stage EC, the optimal extent of dissection based on tumor location remains undefined. This study aimed to establish location-specific LN dissection thresholds to improve outcomes in clinical T1-2N0M0 ESCC.
methodsWe conducted a retrospective analysis of 1017 patients who underwent esophagectomy at two Chinese cancer centers between March 2015 and December 2018, with follow-up until December 2023. LNs were categorized into upper mediastinal (UM), middle mediastinal (MM), lower mediastinal (LM), and abdominal (Abd) compartments. Optimal cut-off values for total and regional LN counts were determined using Maximally Selected Rank Statistics. Overall survival was analyzed using Kaplan-Meier methods, and independent prognostic factors were identified using Cox regression.
resultsDissection of ≥ 17 total LNs, including at least one LM LN and 14 Abd LNs, was associated with significantly improved survival. Location-specific recommendations were upper thoracic tumors, ≥ 19 total LNs (≥ 5 UM, ≥ 14 Abd); middle thoracic tumors, ≥ 17 total LNs (≥ 1 LM, ≥ 6 Abd); lower thoracic tumors, ≥ 18 total LNs (≥ 9 UM, ≥ 1 LM). Multivariate Cox regression identified total and LM LNs as independent prognostic factors for overall survival in the entire cohort, total RLNs in the upper thoracic subgroup, and LM RLNs in the middle thoracic subgroup.
conclusionsThese findings define location-specific LN dissection thresholds that may improve survival outcomes in clinical T1-2N0M0 ESCC. These data provide surgeons with evidence-based guidance for tailoring LN dissection strategies based on tumor location.
Indexed as
Identifiers
40464964What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.